Guided Therapeutics, Inc. (GTHP)
OTCMKTS: GTHP · Delayed Price · USD
0.139
-0.001 (-0.64%)
Jul 23, 2024, 4:00 PM EDT - Market closed
Guided Therapeutics Market Cap
Guided Therapeutics has a market cap or net worth of $7.74 million as of July 24, 2024. Its market cap has decreased by -7.63% in one year.
Market Cap
7.74M
Enterprise Value
9.37M
1-Year Change
-7.63%
Ranking
n/a
Category
Stock Price
$0.14
Market Cap Chart
Since July 24, 2019, Guided Therapeutics's market cap has increased from $821.78K to $7.74M, an increase of 841.89%. That is a compound annual growth rate of 56.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2024 | 7.66M | -7.77% |
| Dec 29, 2023 | 8.31M | -41.85% |
| Dec 30, 2022 | 14.28M | 83.54% |
| Dec 31, 2021 | 7.78M | 97.00% |
| Dec 31, 2020 | 3.95M | 492.49% |
| Dec 31, 2019 | 666.73K | -18.87% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 814.94B |
| Novo Nordisk | 579.91B |
| UnitedHealth Group | 520.32B |
| Johnson & Johnson | 372.29B |
| Merck & Co. | 318.55B |
| AbbVie | 304.29B |
| AstraZeneca | 244.04B |
| Novartis AG | 207.64B |